Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Moderate to Severe Alzheimer's Dementia
NCT00857649Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Dec 2003
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in Alzheimer's disease (AD), sponsored by Lundbeck. Started Dec 2003; status: terminated.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00857649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857649.